These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 19877493)

  • 1. Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression.
    Duman RS
    Dialogues Clin Neurosci; 2009; 11(3):239-55. PubMed ID: 19877493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.
    Licznerski P; Duman RS
    Neuroscience; 2013 Oct; 251():33-50. PubMed ID: 23036622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression.
    Masi G; Brovedani P
    CNS Drugs; 2011 Nov; 25(11):913-31. PubMed ID: 22054117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.
    Manji HK; Quiroz JA; Sporn J; Payne JL; Denicoff K; A Gray N; Zarate CA; Charney DS
    Biol Psychiatry; 2003 Apr; 53(8):707-42. PubMed ID: 12706957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroplasticity and depression].
    Czéh B; Simon M
    Psychiatr Hung; 2005; 20(1):4-17. PubMed ID: 16389729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfection of C6 glioma cells with glia maturation factor upregulates brain-derived neurotrophic factor and nerve growth factor: trophic effects and protection against ethanol toxicity in cerebellar granule cells.
    Pantazis NJ; Zaheer A; Dai D; Zaheer S; Green SH; Lim R
    Brain Res; 2000 May; 865(1):59-76. PubMed ID: 10814733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression.
    Levy MJF; Boulle F; Steinbusch HW; van den Hove DLA; Kenis G; Lanfumey L
    Psychopharmacology (Berl); 2018 Aug; 235(8):2195-2220. PubMed ID: 29961124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator.
    Machado-Vieira R
    J Affect Disord; 2018 Jun; 233():92-99. PubMed ID: 29310970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of depression: the concept of synaptic plasticity.
    Duman RS
    Eur Psychiatry; 2002 Jul; 17 Suppl 3():306-10. PubMed ID: 15177086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Depression: damage of neurons and down-regulation of neurogenesis].
    Li YF; Luo ZP
    Yao Xue Xue Bao; 2004 Nov; 39(11):949-53. PubMed ID: 15696940
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel antidepressant effects of Paeonol alleviate neuronal injury with concomitant alterations in BDNF, Rac1 and RhoA levels in chronic unpredictable mild stress rats.
    Zhu XL; Chen JJ; Han F; Pan C; Zhuang TT; Cai YF; Lu YP
    Psychopharmacology (Berl); 2018 Jul; 235(7):2177-2191. PubMed ID: 29752492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder.
    Soeiro-de-Souza MG; Dias VV; Figueira ML; Forlenza OV; Gattaz WF; Zarate CA; Machado-Vieira R
    Acta Psychiatr Scand; 2012 Nov; 126(5):332-41. PubMed ID: 22676371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural plasticity to stress and antidepressant treatment.
    Duman RS; Malberg J; Thome J
    Biol Psychiatry; 1999 Nov; 46(9):1181-91. PubMed ID: 10560024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of neurotrophic factor and Wnt signaling in depression.
    Voleti B; Duman RS
    Clin Pharmacol Ther; 2012 Feb; 91(2):333-8. PubMed ID: 22205198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal plasticity and survival in mood disorders.
    Duman RS; Malberg J; Nakagawa S; D'Sa C
    Biol Psychiatry; 2000 Oct; 48(8):732-9. PubMed ID: 11063970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evidence for post-insult neuroprotective activity of an evolutionarily conserved motif against excitotoxic neuronal cell death.
    Tran PV
    Neuroreport; 2019 Feb; 30(3):213-216. PubMed ID: 30649102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological reorganization after repeated corticosterone administration in the hippocampus, nucleus accumbens and amygdala in the rat.
    Morales-Medina JC; Sanchez F; Flores G; Dumont Y; Quirion R
    J Chem Neuroanat; 2009 Dec; 38(4):266-72. PubMed ID: 19505571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of neurotrophic factors in the etiology and treatment of mood disorders.
    Duman RS
    Neuromolecular Med; 2004; 5(1):11-25. PubMed ID: 15001809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between brain-derived neurotrophic factor and signal transduction modulators in the regulation of the effects of exercise on synaptic-plasticity.
    Vaynman S; Ying Z; Gomez-Pinilla F
    Neuroscience; 2003; 122(3):647-57. PubMed ID: 14622908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: effects of fluoxetine and MK-801.
    Farley S; Dumas S; El Mestikawy S; Giros B
    Neuropharmacology; 2012 Jan; 62(1):503-17. PubMed ID: 21945287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.